Sqwin S.A. v. Walmart Inc., No. 4:22-cv-01040 (E.D. Tex. Dec. 8, 2023)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

On November 2, 2023, the Court held a hearing to determine the proper construction of the disputed claim terms in Un ited States Patent No. 10,043,176 (“’176 Patent”), U.S. Patent No. 10,621,572 (“’572 Patent”), and U.S. Patent No. 11,195,168 (“’168 Patent”). Having considered the parties’ briefs and arguments at the Markman hearing, (Dkt. #29, #30, #31, # 33, #34 ), the intrinsic and extrinsic evidence, and the applicable law, the Court issues this Claim Construction Order. See Teva Pharms. USA v. Sandoz, Inc., 574 U.S. 318, 331–32, 135 S.Ct.